Press Release: Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares NEW YORK, April 24, 2024 (GLOBE NEWSWIRE) -- I
Dow JonesApr 24 16:01 ET
Cantor Fitzgerald Reiterates Overweight on Intra-Cellular Therapies, Maintains $120 Price Target
Cantor Fitzgerald analyst Charles Duncan reiterates Intra-Cellular Therapies (NASDAQ:ITCI) with a Overweight and maintains $120 price target.
BenzingaApr 24 09:57 ET
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Intra-Cellular Therapies (ITCI)
TipRanksApr 24 08:50 ET
Intra-Cellular Therapies Is Maintained at Buy by Canaccord Genuity
Intra-Cellular Therapies Is Maintained at Buy by Canaccord Genuity
Dow JonesApr 23 10:58 ET
Express News | Canaccord Genuity Maintains Buy on Intra-Cellular Therapies, Raises Price Target to $107
Moomoo 24/7Apr 23 10:49 ET
Express News | Needham Maintains Buy on Intra-Cellular Therapies, Raises Price Target to $90
Moomoo 24/7Apr 22 12:44 ET
10 Best Performing Biotech ETFs in 2024
Yahoo FinanceApr 22 11:10 ET
Buy Rating on Intra-Cellular Therapies as Caplyta Shows Promise in Major Depressive Disorder Market
TipRanksApr 22 10:05 ET
The Analyst Verdict: Intra-Cellular Therapies In The Eyes Of 14 Experts
Providing a diverse range of perspectives from bullish to bearish, 14 analysts have published ratings on Intra-Cellular Therapies (NASDAQ:ITCI) in the last three months.The table below offers a conden
BenzingaApr 22 09:00 ET
Express News | Intra-Cellular Therapies Inc : Mizuho Raises Target Price to $96 From $82
Moomoo 24/7Apr 22 06:41 ET
How Is The Market Feeling About Intra-Cellular Therapies?
Intra-Cellular Therapies's (NYSE:ITCI) short percent of float has risen 4.8% since its last report. The company recently reported that it has 3.47 million shares sold short, which is 4.15% of all regu
BenzingaApr 19 12:00 ET
Analysts Are Bullish on Top Healthcare Stocks: Thermo Fisher (TMO), Intra-Cellular Therapies (ITCI)
TipRanksApr 18 21:50 ET
Top Gap Ups and Downs on Thursday: TSM, ELV, MMC and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
moomoo NewsApr 18 19:28 ET
Express News | Intra-Cellular Therapies Shares Are Trading Lower After the Company Priced a $500 Million Offering
Moomoo 24/7Apr 18 15:42 ET
Analysts Conflicted on These Healthcare Names: Intra-Cellular Therapies (ITCI), Eli Lilly & Co (LLY) and Sanofi (OtherSNYNF)
TipRanksApr 18 08:20 ET
Express News | Reported Earlier, Intra-Cellular Therapies Prices Public Offering Of 6,849,316 Common Shares At $73/Share
Moomoo 24/7Apr 18 03:42 ET
Intra-Cellular Therapies Drops 2%, Prices $500M Equity Financing
Seeking AlphaApr 18 02:47 ET
Express News | Intra-Cellular Therapies Inc : Jefferies Raises Target Price to $105 From $100
Moomoo 24/7Apr 18 02:22 ET
All Shares in Offering Will Be Sold by Intra-Cellular Therapies >ITCI
All Shares in Offering Will Be Sold by Intra-Cellular Therapies >ITCI
Dow JonesApr 17 21:16 ET
Express News | Intra-Cellular Therapies Inc - Pricing of Its Public Offering of 6.8 Mln Shares of Its Common Stock at a Public Offering Price of $73.00 per Share
Moomoo 24/7Apr 17 20:46 ET
No Data
No Data